Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Arch Oral Biol ; 56(10): 1073-80, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21474118

RESUMO

OBJECTIVE: We have previously demonstrated that the mechanism of nifedipine (NIF)-induced gingival overgrowth is related to the observation that proliferation and cell cycle progression of gingival fibroblasts derived from NIF reactive patient (NIFr) are greater than those from NIF non-reactive patient (NIFn). Gingival overgrowth has also been reported to be a result of inhibited apoptosis of gingival fibroblasts. Apoptosis in fibroblasts is induced by lipopolysaccharide (LPS). Thus, we focused upon evaluating whether there is a difference in LPS-induced apoptosis between NIFn and NIFr. METHODS: Both NIFn and NIFr were arrested in DMEM containing 0.5% FBS, stimulated by LPS, and assayed for apoptosis, cell cycle analysis, Western blotting, and caspase activity. RESULTS: Compared to NIFn, the number of apoptotic cells was significantly decreased and the percentage of cells in S and G(2)/M phase was significantly increased in NIFr. The levels of Bax and cytochrome c proteins in NIFr were not up-regulated by LPS compared with NIFn. Both NIFn and NIFr displayed the following changes in protein expression: increased Bad, decreased Bcl-xL, and unchanged Bcl-2 and p53. Caspase-3 and -9 activities were significantly increased by LPS in NIFn but were unchanged in NIFr. Caspase-2 activity remained constant whilst caspase-8 activity significantly increased upon LPS treatment in both NIFn and NIFr. CONCLUSION: Bad, Bax, cytochrome c, p53, and caspases-2, -3, -8, and -9 are pro-apoptotic proteins. Bcl-2 and Bcl-xL are anti-apoptotic proteins. Thus, the mechanism of NIF-induced gingival overgrowth might be related to decreased apoptosis in NIFr through a reduction of Bax, cytochrome c, and caspase-3 and -9.


Assuntos
Apoptose/efeitos dos fármacos , Fibroblastos/efeitos dos fármacos , Gengiva/efeitos dos fármacos , Crescimento Excessivo da Gengiva/patologia , Lipopolissacarídeos/farmacologia , Nifedipino/efeitos adversos , Vasodilatadores/efeitos adversos , Caspase 2/análise , Caspase 2/efeitos dos fármacos , Caspase 3/análise , Caspase 3/efeitos dos fármacos , Caspase 8/análise , Caspase 8/efeitos dos fármacos , Caspase 9/análise , Caspase 9/efeitos dos fármacos , Técnicas de Cultura de Células , Ciclo Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Cisteína Endopeptidases/análise , Cisteína Endopeptidases/efeitos dos fármacos , Citocromos c/análise , Citocromos c/efeitos dos fármacos , Escherichia coli , Fase G2/efeitos dos fármacos , Gengiva/patologia , Crescimento Excessivo da Gengiva/induzido quimicamente , Humanos , Metáfase/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-bcl-2/análise , Proteínas Proto-Oncogênicas c-bcl-2/efeitos dos fármacos , Fase S/efeitos dos fármacos , Proteína Supressora de Tumor p53/análise , Proteína Supressora de Tumor p53/efeitos dos fármacos , Proteína X Associada a bcl-2/análise , Proteína X Associada a bcl-2/efeitos dos fármacos , Proteína de Morte Celular Associada a bcl/análise , Proteína de Morte Celular Associada a bcl/efeitos dos fármacos , Proteína bcl-X/análise , Proteína bcl-X/efeitos dos fármacos
2.
Spine (Phila Pa 1976) ; 33(11): 1242-9, 2008 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-18469699

RESUMO

STUDY DESIGN: Retrospective cohort study. OBJECTIVE: The purpose of this study is to evaluate pulmonary function and quality of life (QOL) in children treated with early spinal fusion for progressive congenital scoliosis. SUMMARY OF BACKGROUND DATA: The relationships between radiographic measures, pulmonary function tests (PFT), and QOL were examined. METHODS.: Twenty-one patients with congenital scoliosis treated with early spinal fusion were evaluated using radiographs, PFT, and the Child Health Questionnaire (CHQ) at 12.6 +/- 3.5 years. They were 6.9 +/- 2.3 years postdefinitive fusion, which occurred at 4.9 +/- 3.1 year of age. The cohort was also divided in two groups, "thoracic fusion" (apex above the thoracolumbar T-L junction) and "nonthoracic fusion" (below T-L junction). RESULTS: Forced vital capacity, forced expiratory volume (FEV1), vital capacity (P < 0.0001), and total lung capacity (P = 0.017) were significantly lower compared with healthy children. CHQ scores were significantly lower than in healthy children in physical function (P = 0.036), general health (P = 0.007), physical summary (P = 0.026), and parental impact/emotional (P = 0.01). Correlation analysis showed that the degrees of thoracic curves were negatively correlated with FEV1 (P < 0.05), family activities, role/social physical (P < 0.05), and physical summary (P < 0.01). The degree of kyphosis was negatively correlated with Self-Esteem (P < 0.01). Patients who had thoracic fusions had shorter spinal height (P = 0.049), lower forced vital capacity (P = 0.004), FEV (P = 0.012), vital capacity (P = 0.031), and reported more pain (P = 0.033) than nonthoracic fused. CONCLUSION: Compared with healthy peers, congenital scoliosis patients treated with early spinal fusion have worse PFT and QOL scores at 6.9 years follow up. Patients with thoracic fusions had shorter spines, worse pulmonary function, and more pain than nonthoracic fused. The results may support alternatives to early spinal fusion such as growing rods, epiphysiodesis, and distraction thoracoplasty. Current efforts are underway to compare outcomes of this study to those of other treatments.


Assuntos
Pulmão/fisiologia , Qualidade de Vida , Escoliose/diagnóstico por imagem , Escoliose/cirurgia , Fusão Vertebral , Adolescente , Adulto , Criança , Estudos de Coortes , Feminino , Seguimentos , Humanos , Masculino , Qualidade de Vida/psicologia , Radiografia , Testes de Função Respiratória/tendências , Estudos Retrospectivos , Escoliose/psicologia , Fusão Vertebral/tendências , Resultado do Tratamento
3.
Seishin Shinkeigaku Zasshi ; 105(9): 1181-5, 2003.
Artigo em Japonês | MEDLINE | ID: mdl-14639942

RESUMO

Japan had a long history of long-term hospital care and is now trying to change it into community-based psychiatry. Implementing comprehensive approach that has already been proven effective through evidence based data in one particular community, one has to overcome several local barriers, if the same approach is to be implemented in different situations, such as differences in socio-cultural background and health care system. This is a report of the activities of Minato Net 21 pointing out the "local barriers" on implementing comprehensive approach in an urban district of Tokyo.


Assuntos
Serviços Comunitários de Saúde Mental/organização & administração , Prestação Integrada de Cuidados de Saúde/organização & administração , Serviços Urbanos de Saúde/organização & administração , Serviços Comunitários de Saúde Mental/tendências , Assistência Integral à Saúde/organização & administração , Assistência Integral à Saúde/tendências , Cultura , Prestação Integrada de Cuidados de Saúde/tendências , Humanos , Tóquio , Serviços Urbanos de Saúde/tendências
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA